Toward a personalized medicine in wake-up stroke?
| dc.authorid | 0000-0002-9704-6173 | |
| dc.authorid | 0000-0003-4292-5717 | |
| dc.authorid | 0000-0001-6494-8923 | |
| dc.contributor.author | Yuluğ, Burak | |
| dc.contributor.author | Hano?lu, Lütfü | |
| dc.contributor.author | Kılıç, Ertuğrul | |
| dc.date.accessioned | 2020-07-17T11:56:26Z | |
| dc.date.available | 2020-07-17T11:56:26Z | |
| dc.date.issued | 2017 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Ana Bilim Dalı | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Fizyoloji Ana Bilim Dalı | |
| dc.department | İstanbul Medipol Üniversitesi, Rektörlük, Rejeneratif ve Restoratif Tıp Araştırmaları Merkezi (REMER) | |
| dc.description.abstract | Ischemic stroke (IS), especially wake-up stroke, is reported to occur with a maximal peak in the morning hoursand usually associated with worse clinical outcome [1-3].Many proposed mechanisms are reported to be responsiblefor the impaired clinical outcomes in IS patients, includinghemostatic and hemodynamic factors. Despite this fact, recent reports have pointed out that circadian pattern independently affects the outcome of IS that persists even whencontrolling for vascular risk factors and different treatmentmodalities (such as anti-platelet or anticoagulant treatment) | |
| dc.identifier.citation | Yuluğ, B., Hano?lu, L. ve Kılıç, E. (2017). Toward a personalized medicine in wake-up stroke? CNS and Neurological Disorders - Drug Targets, 16(10), 1049-1049. https://dx.doi.org/10.2174/1871527316666170727124327 | |
| dc.identifier.doi | 10.2174/1871527316666170727124327 | |
| dc.identifier.endpage | 1049 | |
| dc.identifier.issn | 1871-5273 | |
| dc.identifier.issn | 1996-3181 | |
| dc.identifier.issue | 10 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 1049 | |
| dc.identifier.uri | https://dx.doi.org/10.2174/1871527316666170727124327 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/5557 | |
| dc.identifier.volume | 16 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Bentham Science Publishers Ltd. | |
| dc.relation.ispartof | CNS and Neurological Disorders - Drug Targets | en_US |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | |
| dc.subject | Personalized Medicine | |
| dc.subject | Wake-up Stroke | |
| dc.title | Toward a personalized medicine in wake-up stroke? | |
| dc.type | Editorial |











